Search

everythinglearnresearchcommunity

for

Search:↓

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Lidocaine-loaded microparticles effectively relieve pain and fight bacteria in wounds.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

MPZL3 protein helps control the size of oil glands and the growth of oil-producing cells in both mice and humans.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

Increased K+ permeability alone may not promote hair growth.

Neuropeptides affect hair growth and could be used to control it.

Rosemary may help reduce dyspepsia and gastric cancer risk.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

New compounds may help treat prostate issues without affecting androgen receptors.

Certain astrocytes can protect the brain and improve recovery after a stroke, and a hair loss drug might reduce cancer spread.

DHCer levels in hair could be a biomarker for alopecia progression.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

The treatment promotes hair growth, improves hair density, and reduces skin irritation.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

New nanocarriers improve drug delivery for disease treatment.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.